Home > Products > CD3 & CD30
> Anti-CD3 x Anti-CD30 Bispecific Antibody (IgG-IgG)
Anti-CD3 x Anti-CD30 Bispecific Antibody (IgG-IgG) (CAT#: BSIG-065)
Anti-CD3 x Anti-CD30 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD3 and anti-CD30 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can retarget T cells to tumor cells. It is designed for the research of Neuroblastoma; Osteosarcoma; Hodgkin lymphoma; T cell lymphoma; Anaplastic large cell lymphoma (ALCL) therapy.
There are currently no customer reviews or questions for Anti-CD3 x Anti-CD30 Bispecific Antibody (IgG-IgG) (BSIG-065). Click the button below to contact us or submit your feedback about this product.